An Open-Label, Multicenter, Phase 1 Study of RP2 as a Single Agent and in Combination with Nivolumab in Patients with Solid Tumors: Safety, Efficacy, and Biomarker results
RP2;Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: An Open-Label, Multicenter, Phase 1 Study of RP2 as a Single Agent and in Combination with Nivolumab in Patients with Solid Tumors: Safety, Efficacy, and Biomarker results ### Output: RP2;Nivolumab